A rapid, cost-effective tailed amplicon method for sequencing SARS-CoV-2
The global COVID-19 pandemic has led to an urgent need for scalable methods for clinical diagnostics and viral tracking. Given the small genome size,...
SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets
2.3 million people have died worldwide as a result of SARS-CoV-2 infection. The disease mechanism is mostly unknown, and effective treatment options a...
Assessing critical gaps in COVID-19 testing capacity: the case of delayed results in Ecuador
WHO's preparedness index omits estimations of actual testing capabilities. Ecuador has one of the highest excess death rates globally. Ecuador had a c...
False-negative results of initial RT-PCR assays for COVID-19: A systematic review
False-negative cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have important implications for isolation and risk of transmissio...
Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) Guidelines
Patients with cancer are at higher risk for contracting the COVID-19 infection and are more likely to have higher morbidity and mortality. These guide...
Rapid and Extraction-Free Detection of SARS-CoV-2 from Saliva by Colorimetric Reverse-Transcription Loop-Mediated Isothermal Amplification
Rapid, reliable, and widespread testing is required to curtail the ongoing COVID-19 pandemic. We developed a rapid colorimetric assay using reverse-tr...
Serial interval and incubation period of COVID-19: a systematic review and meta-analysis
Combining findings of existing studies that estimate the average serial interval and incubation period of COVID-19 significantly improves the quality...
Infection and disease spectrum in individuals with household exposure to SARS-CoV-2: A family cluster cohort study
SARS-CoV-2 has a high frequency of transmission among household contacts. Children and adults are less likely to develop the symptomatic disease.